Michael Hall
Otolaryngology/Facial Plastic Surgery · Mount Laurel, NJNPI 1396002606
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 47 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $253 and has fallen 63.8% since, to $92 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in NJ, where the typical reported total is $1,482.
Across 47 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$136
- Genentech USA, Inc.$112
- Amgen$90
- GSK$77
- Kerecis Limited$60
- Lemaitre Vascular, Inc.$53
- plus $393 from 15 others
What the payments were for
- Food & beverage$921100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $136 |
| Genentech USA, Inc. | 5 | $112 |
| Amgen | 3 | $90 |
| GSK | 4 | $77 |
| Kerecis Limited | 4 | $60 |
| Lemaitre Vascular, Inc. | 1 | $53 |
| Optinose US, Inc. | 2 | $44 |
| Lilly USA, LLC | 3 | $41 |
| Sanofi | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 2 | $37 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $33 |
| BD | 1 | $30 |
| Johnson & Johnson | 1 | $29 |
| Biofrontera Inc. | 1 | $25 |
| Medtronic | 1 | $24 |
| Novartis | 1 | $20 |
| Almirall LLC | 1 | $17 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $15 |
| LEO Pharma Inc. | 1 | $14 |
| Revance Therapeutics, Inc. | 1 | $14 |
| Organon | 1 | $12 |
How this compares
$921 in reported general payments places this provider in the 40th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.
See all otolaryngology/facial plastic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 42 | $1,767 |
| Scopolamine | 16 | $1,223 |
| Azelastine Hcl | 43 | $1,140 |
| Omeprazole | 38 | $688 |
| Levocetirizine Dihydrochloride | 38 | $657 |
| Fluticasone Propionate | 23 | $652 |
| Ofloxacin | 40 | $581 |
| Methylprednisolone | 42 | $217 |
| Mometasone Furoate | 18 | $212 |
| Famotidine | 26 | $164 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $83 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Mount Laurel
- Robert MignoneRobbinsville$91K
- Gabriel WongMarlton$9K
- Thomas MazzoniIselin$9K
- Sayani NiyogiIselin$6K
- Lindsay PrincerEnglewood$5K
- Arvind PrabhatShrewsbury$4K
- James LeeWestwood$4K
- Gangadhar SreepadaWayne$4K
- John HannaFlemington$3K
- John CeceWayne$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.